Evaluation of the antitumor activity of the interleukin-12/pulse interleukin-2 combination

Ann N Y Acad Sci. 1996 Oct 31:795:434-9. doi: 10.1111/j.1749-6632.1996.tb52714.x.

Authors

J M Wigginton¹, K L Komschlies, J E Green, G W Cox, C L Jorcyk, T C Back, J L Franco, M J Brunda, R H Wiltrout

Affiliation

¹ Biological Carcinogenesis and Development Program, SAIC Frederick, Maryland, USA.

PMID: 8958976
DOI: 10.1111/j.1749-6632.1996.tb52714.x

No abstract available

MeSH terms

Animals
Antineoplastic Combined Chemotherapy Protocols
Drug Administration Schedule
Immunotherapy
Interleukin-12 / administration & dosage*
Interleukin-2 / administration & dosage*
Mice
Neoplasm Metastasis
Neoplasms, Experimental / therapy*
Survival Analysis

Substances

Interleukin-2
Interleukin-12